164 related articles for article (PubMed ID: 2443836)
21. Identification of the C3b receptor-binding domain in third component of complement.
Becherer JD; Lambris JD
J Biol Chem; 1988 Oct; 263(28):14586-91. PubMed ID: 2971659
[TBL] [Abstract][Full Text] [Related]
22. Identification of functionally relevant determinants on the complement component C3 with monoclonal antibodies.
Burger R; Deubel U; Hadding U; Bitter-Suermann D
J Immunol; 1982 Nov; 129(5):2042-50. PubMed ID: 6181157
[No Abstract] [Full Text] [Related]
23. Segment spanning residues 727-768 of the complement C3 sequence contains a neoantigenic site and accommodates the binding of CR1, factor H, and factor B.
Becherer JD; Alsenz J; Esparza I; Hack CE; Lambris JD
Biochemistry; 1992 Feb; 31(6):1787-94. PubMed ID: 1371073
[TBL] [Abstract][Full Text] [Related]
24. Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b.
Currie MS; Rustagi PK; Wojcieszak R; Ziolkowski L; Ross GD; Logue GL
Blood; 1988 Mar; 71(3):786-90. PubMed ID: 3345346
[TBL] [Abstract][Full Text] [Related]
25. Function of C3 in a humoral response: iC3b/C3dg bound to an immune complex generated with natural antibody and a primary antigen promotes antigen uptake and the expression of co-stimulatory molecules by all B cells, but only stimulates immunoglobulin synthesis by antigen-specific B cells.
Thornton BP; Vetvicka V; Ross GD
Clin Exp Immunol; 1996 Jun; 104(3):531-7. PubMed ID: 9099940
[TBL] [Abstract][Full Text] [Related]
26. Disruption of the internal thioester bond in the third component of complement (C3) results in the exposure of neodeterminants also present on activation products of C3. An analysis with monoclonal antibodies.
Hack CE; Paardekooper J; Smeenk RJ; Abbink J; Eerenberg AJ; Nuijens JH
J Immunol; 1988 Sep; 141(5):1602-9. PubMed ID: 2457622
[TBL] [Abstract][Full Text] [Related]
27. Novel monoclonal antibodies against mouse C3 interfering with complement activation: description of fine specificity and applications to various immunoassays.
Mastellos D; Prechl J; László G; Papp K; Oláh E; Argyropoulos E; Franchini S; Tudoran R; Markiewski M; Lambris JD; Erdei A
Mol Immunol; 2004 Mar; 40(16):1213-21. PubMed ID: 15104126
[TBL] [Abstract][Full Text] [Related]
28. Breakdown of C3 after complement activation. Identification of a new fragment C3g, using monoclonal antibodies.
Lachmann PJ; Pangburn MK; Oldroyd RG
J Exp Med; 1982 Jul; 156(1):205-16. PubMed ID: 6177820
[TBL] [Abstract][Full Text] [Related]
29. Functional and structural characterization of four mouse monoclonal antibodies to complement C3 with potential therapeutic and diagnostic applications.
Subías Hidalgo M; Yébenes H; Rodríguez-Gallego C; Martín-Ambrosio A; Domínguez M; Tortajada A; Rodríguez de Córdoba S; Llorca O
Eur J Immunol; 2017 Mar; 47(3):504-515. PubMed ID: 28083930
[TBL] [Abstract][Full Text] [Related]
30. Three rat monoclonal antibodies to human C3.
Lachmann PJ; Oldroyd RG; Milstein C; Wright BW
Immunology; 1980 Nov; 41(3):503-15. PubMed ID: 6161872
[TBL] [Abstract][Full Text] [Related]
31. Activation of the third component of complement (C3) detected by a monoclonal anti-C3'g' neoantigen antibody in a one-step enzyme immunoassay.
Mollnes TE; Lachmann PJ
J Immunol Methods; 1987 Aug; 101(2):201-7. PubMed ID: 2440954
[TBL] [Abstract][Full Text] [Related]
32. Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.
Medof ME; Iida K; Mold C; Nussenzweig V
J Exp Med; 1982 Dec; 156(6):1739-54. PubMed ID: 7175439
[TBL] [Abstract][Full Text] [Related]
33. Detection of a neoantigen on human C3bi and C3d by monoclonal antibody.
Tamerius JD; Pangburn MK; Müller-Eberhard HJ
J Immunol; 1985 Sep; 135(3):2015-9. PubMed ID: 2410510
[TBL] [Abstract][Full Text] [Related]
34. SDS denaturation of complement factor C3 as a model for allosteric modifications occurring during C3b binding: demonstration of a profound conformational change by means of circular dichroism and quantitative immunoprecipitation.
Nilsson B; Nilsson UR
Immunol Lett; 1986 Aug; 13(1-2):11-4. PubMed ID: 2428739
[TBL] [Abstract][Full Text] [Related]
35. Direct quantitation of activated C3 in human plasma with monoclonal anti-iC3b-C3d-neoantigen.
Kanayama Y; Kurata Y; McMillan R; Tamerius JD; Negoro N; Curd JG
J Immunol Methods; 1986 Apr; 88(1):33-6. PubMed ID: 2420896
[TBL] [Abstract][Full Text] [Related]
36. Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.
Isaacs SN; Argyropoulos E; Sfyroera G; Mohammad S; Lambris JD
J Virol; 2003 Aug; 77(15):8256-62. PubMed ID: 12857894
[TBL] [Abstract][Full Text] [Related]
37. A novel antihuman C3d monoclonal antibody with specificity to the C3d complement split product.
Rasmussen KJ; Skjoedt MO; Vitved L; Skjoedt K; Palarasah Y
J Immunol Methods; 2017 May; 444():51-55. PubMed ID: 28174050
[TBL] [Abstract][Full Text] [Related]
38. Regulatory proteins for the activated third and fourth components of complement (C3b and C4b) in mice. I. Isolation and characterization of factor H: the serum cofactor for the C3b/C4b inactivator (factor I).
Kinoshita T; Nussenzweig V
J Immunol Methods; 1984 Jul; 71(2):247-57. PubMed ID: 6376638
[TBL] [Abstract][Full Text] [Related]
39. Preimplantation embryos cooperate with oviductal cells to produce embryotrophic inactivated complement-3b.
Tse PK; Lee YL; Chow WN; Luk JM; Lee KF; Yeung WS
Endocrinology; 2008 Mar; 149(3):1268-76. PubMed ID: 18039777
[TBL] [Abstract][Full Text] [Related]
40. Antigens of complement factor C3 involved in the interactions with factors I and H.
Nilsson B; Nilsson UR
Scand J Immunol; 1986 Mar; 23(3):357-63. PubMed ID: 2419971
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
